Hypoparathyroidism 2025 Summit:

Translating Science from the Laboratory to the Clinic

Friday, July 11, 2025 | 08:30-16:00 PT
San Francisco, CA
ENDO2025 Pre-meeting

Thursday, April 10, 2025
19:00-20:30  ET
Virtual via Zoom

Register Now

In-person,
full day workshop

ENDO2025
Pre-meeting

Friday, July 11,
2025 in San Francisco

Groundbreaking scientific discoveries in medicine are advancing bench to bedside research in hypoparathyroidism. This exciting summit features academic and industry scientists discussing these basic science breakthroughs and the latest developments of new therapies for hypoparathyroidism.

In-person, full day workshop  |  ENDO2025 Pre-meeting  |  Friday, July 11, 2025 in San Francisco

Topics

Hypoparathyroidism; calcium-sensor receptor (CaSR); calcilytics; hypocalcemia; PTH; palopegteriparatide; canvuparatide; eneboparatide; parathyroid transplant

Learning Objectives

  • Identify unmet needs in the diagnosis and medical management of hypoparathyroidism
  • Outline recent insights in Calcium-Sensor Receptor (CaSR) activation and the potential of calcilytics
  • Discuss advances in PTH basic research and corresponding clinical implications
  • Describe advances in cell therapies research and corresponding clinical implications

Faculty

Maria Luisa Brandi

Summit Co-Chair
(University of Florence)

Aliya A. Khan

Summit Co-chair
(McMaster University)

Featured speakers include:

Thomas J. Gardella

(Harvard Medical School)
Pioneer in PTH receptor biology and peptide therapeutics

Edward F. Nemeth

World-renowned pharmacologist and scientific innovator in calcium-sensing receptor (CaSR) modulation and PTH-based therapies

Diane Krause

(Yale School of Medicine)
Trailblazer in regenerative medicine and stem cell therapies

Sponsors

Gold

AstraZeneca

Silver

Ascendis

BridgeBio

MBX

Septerna

Accreditation

The 2nd Parathyroid Summit will be an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification (MOC) Program of the Royal College of Physicians and Surgeons of Canada, as approved by The Canadian Society of Endocrinology and Metabolism.

Through an agreement between the Royal College of Physicians and Surgeons of Canada and the American Medical Association, physicians may convert Royal College MOC credits to AMA PRA Category 1 Credits™.

Live educational activities recognized by the Royal College of Physicians and Surgeons of Canada as Accredited Group Learning Activities (Section 1) are deemed by the European Union of Medical Specialists (UEMS) eligible for ECMEC®.

Through an agreement between the Royal College of Physicians and Surgeons of Canada and the Qatar Council for Healthcare Practitioners, healthcare practitioners participating in the QCHP CME/CPD program may record MOC Section 1 as QCHP Category 1 credits.

Registration

$175 USD fee, includes breakfast & lunch
Registration for the ENDO2025 meeting is required

ENDO Registration

Select Sessions and Events